Daewoong Pharma (069620) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.057x

Based on the latest financial reports, Daewoong Pharma (069620) has a cash flow conversion efficiency ratio of 0.057x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩57.53 Billion ≈ $38.99 Million USD) by net assets (₩1.00 Trillion ≈ $680.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Daewoong Pharma - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Daewoong Pharma's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Daewoong Pharma for a breakdown of total debt and financial obligations.

Daewoong Pharma Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Daewoong Pharma ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Coastal Financial Corp NASDAQ:CCB	0.120x
CSG Holding Co Ltd SHE:000012	0.033x
Stepan Company NYSE:SCL	0.056x
Shanghai Anoky Group SHE:300067	-0.006x
Beijing Oriental Jicheng Co Ltd SHE:002819	0.017x
Finolex Industries Limited NSE:FINPIPE	0.002x
Hwaxin Environmental Co. Ltd. A SHE:301265	N/A
Astra Microwave Products Limited NSE:ASTRAMICRO	-0.078x

Annual Cash Flow Conversion Efficiency for Daewoong Pharma (2007–2024)

The table below shows the annual cash flow conversion efficiency of Daewoong Pharma from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see 069620 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩926.98 Billion ≈ $628.20 Million	₩51.49 Billion ≈ $34.90 Million	0.056x	-66.35%
2023-12-31	₩802.97 Billion ≈ $544.16 Million	₩132.57 Billion ≈ $89.84 Million	0.165x	+3.52%
2022-12-31	₩741.22 Billion ≈ $502.32 Million	₩118.21 Billion ≈ $80.11 Million	0.159x	+180.10%
2021-12-31	₩702.41 Billion ≈ $476.01 Million	₩39.99 Billion ≈ $27.10 Million	0.057x	-60.80%
2020-12-31	₩695.25 Billion ≈ $471.16 Million	₩100.98 Billion ≈ $68.43 Million	0.145x	+60.35%
2019-12-31	₩635.92 Billion ≈ $430.95 Million	₩57.60 Billion ≈ $39.03 Million	0.091x	+15.90%
2018-12-31	₩607.81 Billion ≈ $411.90 Million	₩47.50 Billion ≈ $32.19 Million	0.078x	-52.52%
2017-12-31	₩631.54 Billion ≈ $427.98 Million	₩103.94 Billion ≈ $70.44 Million	0.165x	+547.03%
2016-12-31	₩604.55 Billion ≈ $409.70 Million	₩15.38 Billion ≈ $10.42 Million	0.025x	-58.87%
2015-12-31	₩580.24 Billion ≈ $393.22 Million	₩35.89 Billion ≈ $24.32 Million	0.062x	+8.59%
2014-12-31	₩455.51 Billion ≈ $308.69 Million	₩25.95 Billion ≈ $17.58 Million	0.057x	-53.94%
2013-12-31	₩437.96 Billion ≈ $296.80 Million	₩54.16 Billion ≈ $36.70 Million	0.124x	+6.17%
2012-12-31	₩386.59 Billion ≈ $261.98 Million	₩45.02 Billion ≈ $30.51 Million	0.116x	-46.45%
2011-12-31	₩362.42 Billion ≈ $245.60 Million	₩78.82 Billion ≈ $53.42 Million	0.217x	+93.60%
2008-12-31	₩278.85 Billion ≈ $188.97 Million	₩31.33 Billion ≈ $21.23 Million	0.112x	+17.33%
2007-12-31	₩269.57 Billion ≈ $182.68 Million	₩25.81 Billion ≈ $17.49 Million	0.096x	--

About Daewoong Pharma

KO:069620 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$1.16 Billion

₩1.71 Trillion KRW

Market Cap Rank

#8492 Global

#240 in Korea

Share Price

₩148300.00

Change (1 day)

-0.87%

52-Week Range

₩129300.00 - ₩194000.00

All Time High

₩272265.92